Is Cencora’s New CFO, $2 Billion Buyback, and Lawsuit Trio Altering The Investment Case For Cencora (COR)?

Simply Wall St. · 2026-06-01T23:11:42Z

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Motley Fool · 2026-06-01T18:39:18Z

Bath & Body Works Sales Fall Amid Turnaround Efforts

The Wall Street Journal · 2026-05-27T12:38:00Z

Cencora nabs ex-CVS exec as new CFO

Healthcare Dive · 2026-05-27T11:14:26Z

3 Market-Beating Stocks to Research Further

StockStory · 2026-05-19T05:32:55Z

Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating

Insider Monkey · 2026-05-18T12:36:45Z

Cencora Legal Probes Test Investor Confidence After Weaker Q2 Revenue Outlook

Simply Wall St. · 2026-05-17T21:13:37Z

The Top 5 Analyst Questions From Cencora’s Q1 Earnings Call

StockStory · 2026-05-16T21:56:55Z

Wells Fargo Maintains Overweight Rating on Cencora (COR)

Insider Monkey · 2026-05-15T13:25:03Z

CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?

Zacks · 2026-05-14T17:06:00Z